|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Karpińska-Kaczmarczyk K, Lewandowska M,
Białek A, Ławniczak M and Urasińska E: Gastric hyperplastic polyps
coexisting with early gastric cancers, adenoma and neuroendocrine
cell hyperplasia. Pol J Pathol. 67:33–38. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ushijima T and Sasako M: Focus on gastric
cancer. Cancer Cell. 5:121–125. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Smith MG, Hold GL, Tahara E and El-Omar
EM: Cellular and molecular aspects of gastric cancer. World J
Gastroenterol. 12:2979–2990. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cunningham D, Allum WH, Stenning SP,
Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ,
Falk SJ, Iveson TJ, et al: Perioperative chemotherapy versus
surgery alone for resectable gastroesophageal cancer. N Engl J Med.
355:11–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vilaseca Cabo A, Musquera Felip M, Ribal
Caparros MJ and Alcaraz Asensio A: Metastasis of gastric carcinoma
simulating a urothelial tumor. Case report and review of the
literature. Arch Esp Urol. 66:885–889. 2013.(In Spanish).
PubMed/NCBI
|
|
7
|
Compare D, Rocco A and Nardone G: Risk
factors in gastric cancer. Eur Rev Med Pharmacol Sci. 14:302–308.
2010.PubMed/NCBI
|
|
8
|
Huang H, Han Y, Zhang C, Wu J, Feng J, Qu
L and Shou C: HNRNPC as a candidate biomarker for chemoresistance
in gastric cancer. Tumour Biol. 37:3527–3534. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li Y, Gong J, Zhang Q, Lu Z, Gao J, Li Y,
Cao Y and Shen L: Dynamic monitoring of circulating tumour cells to
evaluate therapeutic efficacy in advanced gastric cancer. Br J
Cancer. 114:138–145. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oue N, Aung PP, Mitani Y, Kuniyasu H,
Nakayama H and Yasui W: Genes involved in invasion and metastasis
of gastric cancer identified by array-based hybridization and
serial analysis of gene expression. Oncology. 69 (Suppl 1):S17–S22.
2005. View Article : Google Scholar
|
|
11
|
Iorio MV and Croce CM: MicroRNAs in
cancer: Small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Glud M, Rossing M, Hother C, Holst L,
Hastrup N, Nielsen FC, Gniadecki R and Drzewiecki KT:
Downregulation of miR-125b in metastatic cutaneous malignant
melanoma. Melanoma Res. 20:479–484. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ueda T, Volinia S, Okumura H, Shimizu M,
Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, et al:
Relation between microRNA expression and progression and prognosis
of gastric cancer: A microRNA expression analysis. Lancet Oncol.
11:136–146. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Croce C: Introduction to the role of
microRNAs in cancer diagnosis, prognosis, and treatment. Cancer J.
18:213–214. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Holley CL and Topkara VK: An introduction
to small non-coding RNAs: miRNA and snoRNA. Cardiovasc Drugs Ther.
25:151–159. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Iorio MV and Croce CM: microRNA
involvement in human cancer. Carcinogenesis. 33:1126–1133. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen B, Duan L, Yin G, Tan J and Jiang X:
miR-381, a novel intrinsic WEE1 inhibitor, sensitizes renal cancer
cells to 5-FU by up-regulation of Cdc2 activities in 786-O. J
Chemother. 25:229–238. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tang H, Wang Z, Liu Q, Liu X, Wu M and Li
G: Disturbing miR-182 and −381 inhibits BRD7 transcription and
glioma growth by directly targeting LRRC4. PLoS One. 9:e841462014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rothschild SI, Tschan MP, Jaggi R, Fey MF,
Gugger M and Gautschi O: MicroRNA-381 represses ID1 and is
deregulated in lung adenocarcinoma. J Thorac Oncol. 7:1069–1077.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Skalsky RL and Cullen BR: Reduced
expression of brain-enriched microRNAs in glioblastomas permits
targeted regulation of a cell death gene. PLoS One. 6:e242482011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Martinez I, Gardiner AS, Board KF, Monzon
FA, Edwards RP and Khan SA: Human papillomavirus type 16 reduces
the expression of microRNA-381 in cervical carcinoma cells.
Oncogene. 27:2575–2582. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liao C, Wang J, Chen W, He D and Wang H:
miR-381 regulates pituitary adenoma cell growth and migration by
targeting TWIST1. Int J Clin Exp Pathol. 10:242–249. 2017.
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sung CO, Lee KW, Han S and Kim SH: Twist1
is up-regulated in gastric cancer-associated fibroblasts with poor
clinical outcomes. Am J Pathol. 179:1827–1838. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Qian J, Luo Y, Gu X, Zhan W and Wang X:
Twist1 promotes gastric cancer cell proliferation through
up-regulation of FoxM1. PLoS One. 8:e776252013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhu X, Shen H, Yin X, Long L, Xie C, Liu
Y, Hui L, Lin X, Fang Y, Cao Y, et al: miR-186 regulation of Twist1
and ovarian can-cer sensitivity to cisplatin. Oncogene. 35:323–332.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yoshikawa T, Aoyama T, Tanabe K, Nishikawa
K, Ito Y, Hayashi T, Cho H, Miyashita Y, Tsuburaya A and Sakamoto
J: Feasibility and safety of transhiatal approach and D2 total
gastrectomy after neoadjuvant chemotherapy for adenocarcinoma of
the Esophago-gastric junction: A subset analysis of the COMPASS
trial. Dig Surg. 33:424–430. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Burkitt MD, Varro A and Pritchard DM:
Importance of gastrin in the pathogenesis and treatment of gastric
tumors. World J Gastroenterol. 15:1–16. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nielsen CB, Shomron N, Sandberg R,
Hornstein E, Kitzman J and Burge CB: Determinants of targeting by
endogenous and exogenous microRNAs and siRNAs. RNA. 13:1894–1910.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jazdzewski K, Boguslawska J, Jendrzejewski
J, Liyanarachchi S, Pachucki J, Wardyn KA, Nauman A and de la
Chapelle A: Thyroid hormone receptor beta (THRB) is a major target
gene for microRNAs deregulated in papillary thyroid carcinoma
(PTC). J Clin Endocrinol Metab. 96:E546–E553. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bourgeois P, Stoetzel C, Bolcato-Bellemin
AL, Mattei MG and Perrin-Schmitt F: The human H-twist gene is
located at 7p21 and encodes a B-HLH protein that is 96% similar to
its murine M-twist counterpart. Mamm Genome. 7:915–917. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li L and Wu D: miR-32 inhibits
proliferation, epithelial-mesenchymal transition, and metastasis by
targeting TWIST1 in non-small-cell lung cancer cells. Onco Targets
Ther. 9:1489–1498. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bing L, Hong C, Li-Xin S and Wei G:
MicroRNA-543 suppresses endometrial cancer oncogenicity via
targeting FAK and TWIST1 expression. Arch Gynecol Obstet.
290:533–541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li LZ, Zhang CZ, Liu LL, Yi C, Lu SX, Zhou
X, Zhang ZJ, Peng YH, Yang YZ and Yun JP: miR-720 inhibits tumor
invasion and migration in breast cancer by targeting TWIST1.
Carcinogenesis. 35:469–478. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sakamoto A, Akiyama Y, Shimada S, Zhu WG,
Yuasa Y and Tanaka S: DNA methylation in the Exon 1 region and
complex regulation of Twist1 expression in gastric cancer cells.
PLoS One. 10:e01456302015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yuan W, Li T, Mo X, Wang X, Liu B, Wang W,
Su Y, Xu L and Han W: Knockdown of CMTM3 promotes metastasis of
gastric cancer via the STAT3/Twist1/EMT signaling pathway.
Oncotarget. 7:29507–29519. 2016. View Article : Google Scholar : PubMed/NCBI
|
